Transplantation: Efficacy of rapid steroid withdrawal after induction therapy
Nature Reviews Nephrology 13, 2 (2017).
doi:10.1038/nrneph.2016.179
Author: Andrea Aguilar
New data from the Harmony trial show that in renal transplant recipients with a low immunological risk profile, rapid corticosteroid withdrawal after rabbit anti-thymocyte globulin (ATG) or basiliximab induction therapy can be achieved without compromising the efficacy of standard low-dose tacrolimus and mycophenolate mofetil (MMF)-based
Source: Nature Reviews Nephrology - Category: Urology & Nephrology Authors: Andrea Aguilar Tags: Research Highlight Source Type: research
More News: Allergy & Immunology | Corticosteroid Therapy | Prograf | Tacrolimus | Transplants | Urology & Nephrology